Alerts

MEDICAL-ALERT-FDA-Multiple Safety

MEDICAL ALERT Food & Drug Administration 1. Maquet Datascope Corp./Getinge Group Recalls the Cardiosave Hybrid and Cardiosave Rescue Intra-Aortic Balloon…

FDA approves new drug to treat influenza-Xofluza (baloxavir marboxil)

Food & Drug Administration approves new drug to treat influenza Xofluza (baloxavir marboxil) Today, the U.S. Food and Drug Administration approved…

Alert FDA Drug Safety-Recall

From the U.S. Food & Drug Administration   Irbesartan Tablets Sciegen Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Irbesartan Tablets, USP 75…

ALERT-FDA-DRUG SHORTAGE

Food & Drug Administration Drug Shortage Report Trifluoperazine Hydrochloride Tablets Status: Currently in Shortage Date first posted: 10/02/2018 Therapeutic Categories: Psychiatry 1 mg (NDC…

FDA-SAFETY COMMUNICATION-ALERT-Alcon CyPass Micro-Stent

UPDATE: Potential Eye Damage from Alcon CyPass Micro-Stent Used to Treat Open-Angle Glaucoma: FDA Safety Communication 24 October 2018 Audience People who…

FDA SAFETY COMMUNICATION

Food & Drug Administration SAFETY COMMUNICATION Increased Risk of Corneal Haze Associated with the Raindrop Near Vision Inlay: FDA Safety…

FDA ALERT-MEDWATCH

Food & Drug Administration Alert-MEDWATCH 23 October 2018 MedWatch – The FDA Safety Information and Adverse Event Reporting Program A new MedWatch…

FDA Drug Shortage Alert

U.S. Food & Drug Administration is reporting, Drug Shortages for, Ondansetron Hydrochloride Injection Diltiazem Hydrochloride ER (Twice-a-Day) Capsules For more information from the…

Naloxone Recall-FDA

From the Food and Drug Administration Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL in the Carpujectâ„¢…

FDA-Recalls AFX Endovascular AAA Systems

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these…